Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Cannabis Neurobiology And Schizophrenia Risk in Youth: A Multi-Omics Translation

Objetivo

Schizophrenia is among the most disabling Schizophrenia is one of the most disabling psychiatric disorders with great societal burden, yet its treatment and prevention are stalled by the severe lack of mechanistic understanding. At the same time, cannabis, the most used illicit drug worldwide, is a strong, modifiable risk factor, especially during adolescence when the brain is still maturing. With rapidly increasing use of potent cannabis among youth, uncovering how it disrupts brain development and contributes to schizophrenia risk has become an urgent scientific and public health priority.

CANARY introduces a novel translational framework that bridges neuroscience and psychiatric epidemiology: from mouse to human and from mechanism to clinic.

Aim 1 reveals joint transcriptional and epigenetic disruptions by THC (primary psychoactive component in cannabis), by generating the first temporal, cell-type resolved multi-omics atlas of THC effects in adolescent mouse brain.

Aim 2 maps these molecular signatures to human schizophrenia genomics using advanced cross-species multi-omic integrations, defining THC-schizophrenia shared genes, enhancers, and biological networks.

Aim 3 translates these mechanisms into clinical insight through (i) mechanism-informed individual genetic scores to identify vulnerable subgroups, and (ii) drug repurposing validated in real-world Nordic registry data using target-trial emulation.

CANARY transforms psychiatry from descriptive associations to mechanistic precision. By comprehensively integrating multi-omics and population-scale data, it clarifies how THC affects youth brain and how this can be translated to actionable clinical insights with real-world validation. Amid the accelerating global rise of cannabis use, this multi-modal framework delivers the urgently needed mechanistic foundation to guide targeted prevention and reveal new therapeutic options, establishing a scalable, mechanism-anchored blueprint for precision psychiatry.

Ámbito científico (EuroSciVoc)

Este proyecto aún no se ha clasificado con EuroSciVoc.
Sugiera los ámbitos científicos que considere más relevantes y ayúdenos a mejorar nuestro servicio de clasificación.

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-ERC - HORIZON ERC Grants

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) ERC-2026-STG

Ver todos los proyectos financiados en el marco de esta convocatoria

Institución de acogida

KAROLINSKA INSTITUTET
Aportación neta de la UEn
€ 1 500 000,00
Dirección
NOBELS VAG 5
171 77 STOCKHOLM
Suecia
Región
Östra Sverige Stockholm Stockholms län
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 1 500 000,00

Beneficiarios (1)